Can we assume on this basis that at 60% readout we will have overwhelming efficacy ?
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-364
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.224B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $9.575M | 8.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 47398 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 178807 | 21 |
View Market Depth
| Last trade - 13.01pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |